CO OLESTA AM 40+10+25MG TABLET

CO OLESTA AM 40+10+25mg tablet is a combination medication that contains three active ingredients: Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide. It is available in tablet form and is prescribed for the management of hypertension (high blood pressure). The combination of these three medications helps control blood pressure by relaxing blood vessels and reducing fluid retention.

Uses:

CO OLESTA AM 40+10+25mg tablets are primarily used for the following purposes:

1. Hypertension: The combination of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide is effective in lowering high blood pressure. It helps relax and widen blood vessels, making it easier for the heart to pump blood. Additionally, Hydrochlorothiazide reduces fluid retention, thus aiding in blood pressure control.

Side Effects:

While CO OLESTA AM 40+10+25mg tablets can effectively manage blood pressure, they may also cause certain side effects. Not everyone will experience these side effects, and their severity can vary. Common side effects of CO OLESTA AM 40+10+25mg tablets may include:

1. Dizziness or lightheadedness
2. Fatigue or tiredness
3. Swelling in the ankles or feet
4. Flushing or warmth in the face
5. Headache
6. Increased urination
7. Muscle cramps or weakness
8. Dry mouth

It’s important to inform your healthcare provider if you experience any persistent or severe side effects while taking CO OLESTA AM 40+10+25mg tablets.

When Not to Use:

CO OLESTA AM 40+10+25mg tablets should not be used in certain situations. These include:

1. Allergy: If you have a known allergy or hypersensitivity to Olmesartan Medoxomil, Amlodipine, Hydrochlorothiazide, or any other components of the tablet, you should avoid using this medication.
2. Pregnancy: CO OLESTA AM 40+10+25mg tablets are not recommended during pregnancy, particularly during the second and third trimesters. It is important to consult with your healthcare provider to discuss alternative options if you are pregnant or planning to become pregnant.
3. Breastfeeding: The safety of the combination medication during breastfeeding has not been established. It is advisable to consult with your healthcare provider to weigh the potential risks and benefits before using CO OLESTA AM 40+10+25mg tablets while breastfeeding.
4. Severe Renal Impairment: Individuals with severe renal (kidney) impairment may require dosage adjustments or should avoid using CO OLESTA AM 40+10+25mg tablets due to the risk of worsening kidney function.

Always consult your healthcare provider or pharmacist for specific guidance regarding the appropriate use of CO OLESTA AM 40+10+25mg tablets and any potential contraindications based on your individual medical history.